ITMI971119A0 - - Google Patents
Info
- Publication number
- ITMI971119A0 ITMI971119A0 ITMI971119A ITMI971119A ITMI971119A0 IT MI971119 A0 ITMI971119 A0 IT MI971119A0 IT MI971119 A ITMI971119 A IT MI971119A IT MI971119 A ITMI971119 A IT MI971119A IT MI971119 A0 ITMI971119 A0 IT MI971119A0
- Authority
- IT
- Italy
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (30)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001119A IT1291366B1 (it) | 1997-05-14 | 1997-05-14 | Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale |
| KR1019997010372A KR100592193B1 (ko) | 1997-05-14 | 1998-05-06 | 글리시리진산과 항바이러스 활성을 갖는 적어도 하나의 단백질로 이루어진 항바이러스성 제약 조성물 |
| TR1999/02730T TR199902730T2 (xx) | 1997-05-14 | 1998-05-06 | Glikrizikasit ve antiviral etkinlik kazand�r�lm�� en az�ndan bir proteini i�eren farmas�tik antiviral bile�im. |
| EP98925588A EP0980254B1 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| IL13265198A IL132651A0 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity |
| GEAP19985126A GEP20022672B (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical Composition |
| AT98925588T ATE212232T1 (de) | 1997-05-14 | 1998-05-06 | Antivirale pharmazeutische zusammensetzungen welche glycyrrhizinsäure und mindestens ein protein mit antiviraler wirksamkeit enthalten |
| PCT/EP1998/002797 WO1998051334A1 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| US09/423,611 US6329339B1 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| HK00107849.8A HK1028347B (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| SI9830118T SI0980254T1 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| AU77646/98A AU740944B2 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| EA199901024A EA003126B1 (ru) | 1997-05-14 | 1998-05-06 | Антивирусная фармацевтическая композиция, содержащая глицирризиновую кислоту и, по меньшей мере, один белок, имеющий активность в отношении вируса простого герпеса типа 1 |
| HU0002985A HU224956B1 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| DE69803565T DE69803565T2 (de) | 1997-05-14 | 1998-05-06 | Antivirale pharmazeutische zusammensetzungen welche glycyrrhizinsäure und mindestens ein protein mit antiviraler wirksamkeit enthalten |
| CA002289550A CA2289550A1 (en) | 1997-05-14 | 1998-05-06 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| CZ19993991A CZ291932B6 (cs) | 1997-05-14 | 1998-05-06 | Farmaceutický prostředek s antivirovým účinkem, obsahující kyselinu glycyrrhizovou a alespoň jeden protein projevující antivirový účinek |
| DK98925588T DK0980254T3 (da) | 1997-05-14 | 1998-05-06 | Farmaceutisk antiviruspræparat omfattende glycyrrhizinsyre og mindst et protein udstyret med antiviral aktivitet |
| PT98925588T PT980254E (pt) | 1997-05-14 | 1998-05-06 | Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral |
| CN98805037A CN1114447C (zh) | 1997-05-14 | 1998-05-06 | 含有甘草酸和至少一种具有抗病毒活性的蛋白质的抗病毒药物组合物 |
| ES98925588T ES2170501T3 (es) | 1997-05-14 | 1998-05-06 | Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica. |
| PL98336802A PL189218B1 (pl) | 1997-05-14 | 1998-05-06 | Przeciwwirusowa kompozycja farmaceutyczna obejmująca kwas glicyryzowy i przynajmniej jedno białko oaktywności przeciwwirusowej |
| SK1544-99A SK283584B6 (sk) | 1997-05-14 | 1998-05-06 | Farmaceutický prostriedok s antivírusovým účinkom obsahujúci kyselinu glycyrhizovú a aspoň jeden proteín prejavujúci antivírusový účinok |
| JP54879998A JP2001525814A (ja) | 1997-05-14 | 1998-05-06 | グリシルリジン酸及び抗ウイルス活性を有する蛋白質を少なくとも一つ含む、抗ウイルス薬剤組成物 |
| ZA983917A ZA983917B (en) | 1997-05-14 | 1998-05-08 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| ARP980102218A AR012849A1 (es) | 1997-05-14 | 1998-05-13 | Composicion farmaceutica antivirica. |
| UA99126790A UA63955C2 (uk) | 1997-05-14 | 1998-06-05 | Фармацевтична антивірусна композиція |
| IL132651A IL132651A (en) | 1997-05-14 | 1999-10-29 | Antiviral pharmaceutical preparation containing glyceric acid and at least one protein with antiviral activity |
| BG103968A BG64748B1 (bg) | 1997-05-14 | 1999-12-08 | Противовирусен фармацевтичен състав |
| JP2008331229A JP2009102370A (ja) | 1997-05-14 | 2008-12-25 | グリシルリジン酸及び抗ウイルス活性を有する蛋白質を少なくとも一つ含む、抗ウイルス薬剤組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001119A IT1291366B1 (it) | 1997-05-14 | 1997-05-14 | Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI971119A0 true ITMI971119A0 (h) | 1997-05-14 |
| ITMI971119A1 ITMI971119A1 (it) | 1998-11-14 |
| IT1291366B1 IT1291366B1 (it) | 1999-01-07 |
Family
ID=11377123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT97MI001119A IT1291366B1 (it) | 1997-05-14 | 1997-05-14 | Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6329339B1 (h) |
| EP (1) | EP0980254B1 (h) |
| JP (2) | JP2001525814A (h) |
| KR (1) | KR100592193B1 (h) |
| CN (1) | CN1114447C (h) |
| AR (1) | AR012849A1 (h) |
| AT (1) | ATE212232T1 (h) |
| AU (1) | AU740944B2 (h) |
| BG (1) | BG64748B1 (h) |
| CA (1) | CA2289550A1 (h) |
| CZ (1) | CZ291932B6 (h) |
| DE (1) | DE69803565T2 (h) |
| DK (1) | DK0980254T3 (h) |
| EA (1) | EA003126B1 (h) |
| ES (1) | ES2170501T3 (h) |
| GE (1) | GEP20022672B (h) |
| HU (1) | HU224956B1 (h) |
| IL (2) | IL132651A0 (h) |
| IT (1) | IT1291366B1 (h) |
| PL (1) | PL189218B1 (h) |
| PT (1) | PT980254E (h) |
| SK (1) | SK283584B6 (h) |
| TR (1) | TR199902730T2 (h) |
| UA (1) | UA63955C2 (h) |
| WO (1) | WO1998051334A1 (h) |
| ZA (1) | ZA983917B (h) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7151082B2 (en) * | 1999-02-11 | 2006-12-19 | The Feinstein Institute For Medical Research | Antagonists of HMG1 for treating inflammatory conditions |
| US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| AU2003225073A1 (en) * | 2002-04-18 | 2003-11-03 | The University Of Iowa Research Foundation | Methods of inhibiting and treating bacterial biofilms by metal chelators |
| US7696169B2 (en) * | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| CA2882022A1 (en) * | 2003-09-11 | 2005-03-24 | Walter Newman | Monoclonal antibodies against hmgb1 |
| US7964706B2 (en) * | 2004-10-22 | 2011-06-21 | Medimmune, Llc | High affinity antibodies against HMGB1 and methods of use thereof |
| WO2007011606A2 (en) * | 2005-07-18 | 2007-01-25 | Critical Therapeutics, Inc. | USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS |
| IT1391170B1 (it) * | 2008-08-07 | 2011-11-18 | D M G Italia S R L | Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale |
| CA2809031C (en) * | 2010-08-25 | 2018-10-16 | Weijian Zhang | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| US9416151B2 (en) | 2010-08-25 | 2016-08-16 | Lurong ZHANG | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| US20170049863A1 (en) * | 2014-02-21 | 2017-02-23 | National University Corporation Tokyo University Of Marine Science And Technology | Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes |
| US12447166B2 (en) | 2016-02-25 | 2025-10-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| SG11201806868TA (en) * | 2016-02-25 | 2018-09-27 | Applied Biological Laboratories Inc | Compositions and methods for protecting against airborne pathogens and irritants |
| CN109022351B (zh) * | 2018-09-28 | 2021-10-19 | 广州奇龙生物科技有限公司 | 重组人溶菌酶的新应用 |
| EP3928785B1 (en) * | 2020-04-27 | 2024-07-31 | Guangzhou Century Clinical Research Co., Ltd | Medicament and food for use in preventing or treating novel coronavirus pneumonia covid-19 |
| CN112135625B (zh) * | 2020-04-27 | 2021-07-06 | 广州新创忆药物临床研究有限公司 | 一种预防或治疗covid-19新冠肺炎的药物及其应用 |
| JP7543427B2 (ja) * | 2020-04-27 | 2024-09-02 | 広州新創憶薬物臨床研究有限公司 | 抗新型コロナウイルス感染症の医薬品、食品、及び使用 |
| MX2021005280A (es) * | 2021-05-04 | 2022-02-23 | Spv Timser S A P I De C V | Composicion farmaceutica que contiene triterpenoides pentaciclicos. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085800B2 (ja) * | 1986-12-19 | 1996-01-24 | エーザイ株式会社 | 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤 |
| JP2838720B2 (ja) * | 1989-10-31 | 1998-12-16 | ゼリア新薬工業株式会社 | 安定な点眼剤 |
| JP4056099B2 (ja) * | 1996-05-09 | 2008-03-05 | 森永乳業株式会社 | 水生動物の寄生生物性疾患の予防および治療剤 |
-
1997
- 1997-05-14 IT IT97MI001119A patent/IT1291366B1/it active IP Right Grant
-
1998
- 1998-05-06 GE GEAP19985126A patent/GEP20022672B/en unknown
- 1998-05-06 PL PL98336802A patent/PL189218B1/pl not_active IP Right Cessation
- 1998-05-06 WO PCT/EP1998/002797 patent/WO1998051334A1/en not_active Ceased
- 1998-05-06 CZ CZ19993991A patent/CZ291932B6/cs not_active IP Right Cessation
- 1998-05-06 TR TR1999/02730T patent/TR199902730T2/xx unknown
- 1998-05-06 AT AT98925588T patent/ATE212232T1/de not_active IP Right Cessation
- 1998-05-06 DK DK98925588T patent/DK0980254T3/da active
- 1998-05-06 ES ES98925588T patent/ES2170501T3/es not_active Expired - Lifetime
- 1998-05-06 JP JP54879998A patent/JP2001525814A/ja not_active Ceased
- 1998-05-06 CN CN98805037A patent/CN1114447C/zh not_active Expired - Fee Related
- 1998-05-06 SK SK1544-99A patent/SK283584B6/sk not_active IP Right Cessation
- 1998-05-06 EA EA199901024A patent/EA003126B1/ru not_active IP Right Cessation
- 1998-05-06 EP EP98925588A patent/EP0980254B1/en not_active Expired - Lifetime
- 1998-05-06 HU HU0002985A patent/HU224956B1/hu not_active IP Right Cessation
- 1998-05-06 US US09/423,611 patent/US6329339B1/en not_active Expired - Fee Related
- 1998-05-06 PT PT98925588T patent/PT980254E/pt unknown
- 1998-05-06 DE DE69803565T patent/DE69803565T2/de not_active Expired - Fee Related
- 1998-05-06 KR KR1019997010372A patent/KR100592193B1/ko not_active Expired - Fee Related
- 1998-05-06 IL IL13265198A patent/IL132651A0/xx active IP Right Grant
- 1998-05-06 AU AU77646/98A patent/AU740944B2/en not_active Ceased
- 1998-05-06 CA CA002289550A patent/CA2289550A1/en not_active Abandoned
- 1998-05-08 ZA ZA983917A patent/ZA983917B/xx unknown
- 1998-05-13 AR ARP980102218A patent/AR012849A1/es active IP Right Grant
- 1998-06-05 UA UA99126790A patent/UA63955C2/uk unknown
-
1999
- 1999-10-29 IL IL132651A patent/IL132651A/en not_active IP Right Cessation
- 1999-12-08 BG BG103968A patent/BG64748B1/bg unknown
-
2008
- 2008-12-25 JP JP2008331229A patent/JP2009102370A/ja not_active Ceased
Also Published As
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |